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Abstract: The increasing interest in effort towards creating alternative therapies have led to 
exciting breakthroughs in the attempt to bio-fabricate and engineer live tissues. This has been 
particularly evident in the development of new approaches applied to reconstruct corneal 
tissue. The need for tissue-engineered corneas is largely a response to the shortage of donor 
tissue and the lack of suitable alternative biological scaffolds preventing the treatment of 
millions of blind people worldwide. This review is focused on recent developments in 
corneal tissue engineering, specifically on the use of self-assembling peptide amphiphiles 
for this purpose. Recently, peptide amphiphiles have generated great interest as therapeutic 
molecules, both in vitro and in vivo. Here we introduce this rapidly developing field, and 
examine innovative applications of peptide amphiphiles to create natural bio-prosthetic 
corneal tissue in vitro. The advantages of peptide amphiphiles over other biomaterials, 
namely their wide range of functions and applications, versatility, and transferability are also 
discussed to better understand how these fascinating molecules can help solve current 
challenges in corneal regeneration.  
Keywords: cornea; corneal diseases; peptide amphiphiles; bioactive molecules; tissue 
engineering; corneal tissue engineering; wound healing 
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1. Introduction 
The cornea is the transparent, outermost part of the eye that serves as the primary refractive organ in 
the visual system [1]. Diseases, traumas, or injuries are the leading causes of corneal blindness and its 
prevalence varies from country to country, and even from one population to another, depending on many 
factors such as availability and general standards of eye care. It is estimated that 180 million people 
worldwide have severely impaired vision in both eyes, resulting in a considerable social and economic 
impact [2]. Corneal disease remains a major cause of blindness, second only to cataracts. Although  
multi-factorial, the vast majority of corneal clinical cases would benefit from a suitable corneal 
replacement. However, there is currently a lack of donor cornea availability. The main factor behind this 
donor shortage is that, in many parts of the world, there are limitations in the storage and distribution of 
corneal tissue, as well as cultural and/or religious barriers [3]. Moreover, the supply of human corneal 
tissue is expected to diminish even further due to the increasing popularity of refractive surgery (such as 
LASIK), a technique that renders these corneas unsuitable for donation. However, even considering the 
best conditions, donor grafts are typically variable in quality and usually fail due to immunological 
rejection or endothelial decompensation resulting in an 18% failure rate for initial grafts [4].  
In the context of these limitations, the field of corneal tissue engineering has made considerable 
advances in the last 10 years, focusing on alternative means of replacing damaged corneal tissue. 
Approaches have included development of fully artificial keratoprostheses, use of decellularized tissue 
scaffolding from animal or human sources, and use of acellular, cross-linked collagen constructs as 
corneal replacements [5,6]. Presently, bioengineered corneal substitutes are already available for 
experimental clinical purposes such as corneal grafting [7,8]. In addition to their clinical applications for 
transplantation and wound healing enhancement, these engineered tissues also represent attractive  
in vitro models of human tissues for various biological purposes. However, whilst much work is going 
on in this research area [9,10], this review will instead focus on ongoing studies using different 
biomaterials to create new corneal tissues, and more specifically, work involving peptide amphiphiles 
(PAs) in corneal tissue engineering. The advantages of using these biomaterials and the significant 
challenges involved will also be discussed, along with the many future perspectives in the field. 
2. Challenges in Corneal Tissue Engineering  
The final purpose of corneal tissue engineering is the fabrication of corneal tissue equivalents able to 
improve the function of their injured or diseased natural counterparts. However, constructing a cornea 
presents several challenges to the field of tissue engineering due to the very specific structural and 
cellular properties of the organ. Strength, shape, transparency, biocompatibility, and molecular and 
cellular compositions are important properties of the cornea that remain difficult to replicate in vitro. 
Moreover, assembly and recovery of the engineered corneal tissues whilst maintaining minimal 
manipulation before and during grafting remains an important part of the bio-fabrication process and 
still requires intense study and optimization.  
At a macroscopic level, from an anterior to a posterior location, the human cornea is composed of a 
non-keratinized multi-layered epithelium, the Bowman’s membrane, a 0.5 mm-thick stroma, the 
Descemet’s membrane, and an endothelium [11] (Figure 1). The stroma accounts for 90% of the volume 
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of the cornea, and is essential to support the mechanical and refractive properties of the organ. These 
properties are based on the ultrastructural organization of the stroma’s extracellular matrix, comprised 
by a pseudocrystalline lattice of highly-ordered collagen fibers and proteoglycans, and sparsely 
populated by quiescent stromal cells, the keratocytes. This arrangement plays a fundamental role in the 
structure and function of the cornea. Specifically, the orderly array of collagen fibers and the refractive 
index matching of these fibrils by interstitial proteoglycans play a significant role in the transparency of 
the tissue [12]. Stromal collagen type-I fibers have a 20–35 nm diameter, and are aligned parallel to each 
other with regular 30-nm spacing between fibrils. This regular spacing is thought to be regulated by 
stromal-specific proteoglycans, which have been observed to form ring-like structures around collagen 
fibrils in the normal cornea [13]. The aligned fibers are grouped into layers called lamellae, which are 
stacked in an alternating lattice [14]. The thickness of the stroma and arrangement of the collagen fibers 
are optimal for light transmission through the cornea, with minimal light scatter. 
 
Figure 1. The human central cornea in cross-section. The outer-, anterior-most surface of 
the cornea comprises a non-keratinized, multi-layered epithelium (blue) supported by a 
basement membrane and above the Bowman’s layer (yellow). The middle stromal tissue 
comprises 90% of the cornea’s thickness, and is sparsely populated with keratocytes (green) 
interspersed within approximately 200 lamellae of dense, collagen- and proteoglycan-rich 
extracellular matrix (lines). The innermost posterior tissue consists of a single layer of 
endothelial cells (red) supported by the Descemet’s membrane (grey). 
Corneal transparency also has a cellular contribution. Keratocytes express certain proteins, known as 
corneal crystallins, which are thought to match the refractive index of the cell cytoplasm with the 
surrounding matrix material [15]. In addition, the cornea is avascular, a property maintained by its  
anti-angiogenic milieu [16] which, if eliminated, can lead to blood vessel ingrowth and loss of  
transparency [17]. Moreover, the overall structure of the stroma is dependent on its hydration state, a 
feature regulated by the corneal epithelial [18] and endothelial layers [19]. Furthermore, the correct 
development and function of these tissue layers are dependent on the presence of a well-developed 
network of nociceptive neurons [20]. From this perspective, any attempts to engineer corneal tissues 
must take into consideration the multi-cellular nature of the cornea, and the intricate direct and indirect 
interaction maintained between the various tissues. 
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3. Previous Approaches to Engineer Corneal Tissue: Top-Down or Bottom-Up?  
In recent years, the development of tissue-engineered corneal substitutes emerged as an alternative 
method to overcome several issues related to corneal transplantation, namely the relatively high  
host-rejection rate of keratoprosthesis. In this context, different corneal stromal equivalents have been 
developed using various biomaterials such as decellularized corneas [21], amniotic membrane [22] or 
scaffolds produced from collagen type I [23], fibrin agarose [8,24–26], fish scales [27], chitosan [28], 
caprolactone [29], or poly(ester urethane) urea [30]. For instance, Du et al. [22] used amniotic membrane 
as a biomaterial upon which human corneal epithelium stem cells were tested as therapy for limbal stem 
cell deficiency. Among all the materials used for the production of biocompatible scaffolds, collagen-based 
constructs seem to be the most interesting. A number of examples can be seen in the work of Griffith 
and co-workers, where considerable effort was made to create and optimize scaffolds produced from 
cross-linked collagen [31], recombinant human collagen [32], and bio-functionalized collagen [33] for 
corneal tissue engineering purposes. Although many of these approaches are currently being tested in 
the clinic, none has had the broad success and acceptance of fresh tissue transplantation. The reason for 
this discrepancy might be due to the different strategies used to produce bioengineered tissues in general, 
and corneal tissue equivalents in particular.  
Traditional tissue engineering typically employs what is called a top-down approach. This is based 
on the use of scaffolds, necessarily biocompatible and optionally biodegradable, to recreate the 
appropriate microarchitecture of the natural tissue and serve as support for cell attachment and growth. 
Cells seeded on such materials are expected to populate them while maintaining their native phenotype, 
and use these scaffolds as support while creating a suitable growth environment (e.g., by depositing their 
own extracellular matrix). Theoretically, a 3D scaffold with a precise shape, composition and internal 
organization can provide a perfect microenvironment allowing the organization of individual cells into 
a functional tissue [34]. However, the design a priori of scaffolds with mechanical, physiochemical and 
biological properties ideal for a specific tissue has not been yet realized, and is probably beyond current 
knowledge and technology. On the other hand, bottom-up approaches are emerging as an alternative for 
creating highly organized tissues, and using these modular units as building blocks to engineer biological 
tissues. These modular units can be fabricated using different methods such as self-assembled 
aggregation [35], microfabrication of cell-laden hydrogels [36] and extracellular matrix [37], 
overlapping of cell sheets [38], or direct printing of tissues [39]. Once bio-fabricated, these blocks can 
be stacked, assembled, or combined to form larger tissues or whole organs [40]. Commonly, the bottom-up 
approaches aim at providing cells with a guiding template to direct cell-driven organization and tissue 
formation. In other words, cells are instructed to recapitulate natural tissue differentiation, growth and 
morphogenesis in vitro. These strategies have allowed the creation of modular tissues with native-type 
composition and micro-architecture, without the need to introduce scaffolds and with better perceived 
outcomes in downstream applications (e.g., grafting). The difference between top-down and bottom-up 
strategies constitutes an important topic for future approaches to corneal tissue engineering, as discussed 
in a recent review article focused on the subject [41]. 
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4. Peptide Amphiphiles in Tissue Engineering  
Recently, small bioactive molecules capable of self-assembly have attracted considerable interest as 
new functional materials with broad applications in tissue engineering and regenerative medicine [42–44]. 
Specifically, these are self-assembling molecules used to produce biocompatible materials for three 
dimensional cell culture [45,46], drug delivery [47,48], inhibition of bacterial growth [49,50], delivery 
of therapeutic molecules [51], or as scaffolds for cell therapy [52–55]. Concerning their use as delivery 
systems, it is important to understand if and how supramolecular nanostructures can cross the diffusion 
barriers present in the human body such as the blood-brain barrier or, relevant to corneal applications, 
the corneal epithelial or endothelial layers. One of the most promising types of such molecules comprises 
small synthetic peptides. These molecules incorporate small bioactive or bio-inspired peptide sequences, 
with several advantages over the use of whole-protein matrixes, including sourcing (i.e., easier 
isolation/production and purification), reduced immunogenicity [56], presentation (i.e., more effective 
and controlled density and orientation of the bioactive motives [57]), and stability [58]. In addition, they 
can be rationally designed to have amphiphilic characteristics, i.e., to contain both hydrophilic and 
hydrophobic domains that help them self-assemble into a variety of supramolecular 3D nanostructures, 
such as tubes, tapes, fibres, vesicles and micelles, among other architectures [52,59–61] (Figure 2). 
However, despite this variability, or maybe because of it, there are currently no set rules for this rational 
design. In other words, there is still much work to be done regarding the development of a 
supramolecular code that will allow us to predict the self-assembly of hierarchical architectures and  
bio-function based solely on the primary structure of amphiphilic peptides [62].  
Amphiphilic peptides can be classified as peptide sequences with amphiphilic properties arising from 
hydrophobic and hydrophilic residues, whereas peptide amphiphiles (PAs) constitute a subset of the 
former comprising a peptide sequence linked to a hydrophobic tail [63]. PAs can be easily synthesized 
by standard peptide synthesis protocols by standard solid phase chemistry that ends with the alkylation 
of the NH2 terminus of the peptide; their structural folding and stability have been extensively 
characterized [64,65]. However, and although small and medium-sized peptides are easily obtained in 
high yields, large peptide sequences (i.e., longer than 50 amino acids) are still difficult to produce and 
purify by direct chemical synthesis [66]. An example of a representative PA contains three segments: a 
hydrophobic sequence, commonly a lipid chain that guides aggregation through hydrophobic collapse, 
a β-sheet-forming peptide that promotes nanofiber formation through the formation of hydrogen bonds, 
and a peptide segment, usually less than 15 amino acids long, with ionisable side chains and a  
bio-functional amino acid sequence [67]. In this review we will give specific attention to the 
characteristics and applications of such PAs.  
The self-assembly mechanism involved in these single-tailed PAs usually occurs after changes in  
pH [68], mixing of oppositely charged PAs [69], or addition of multivalent cations [54] to generate 
electrostatic repulsion between the PA molecules. The supramolecular self-assembly of PAs in aqueous 
environments is governed by at least three major forces: the interactions between the hydrophobic tails, 
the electrostatic repulsions between charged groups, and the hydrogen bonding among the middle 
peptide segments [52]. The derived ultrastructure of self-assembled PAs reflects a balance of each force 
contribution, and has dimensions similar to those of fibrils from natural extracellular matrix. 
Specifically, taking advantage of their amphiphilic properties, the hydrophobic alkyl tails of PAs 
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solubilized in aqueous solutions are packed in the center of the fiber while the hydrophilic peptide 
segments are exposed to the aqueous environment, forming an external corona. As such, these molecules 
can be designed to display bioactive epitopes at the surface of the self-assembled nanostructure, while 
keeping intermolecular hydrogen bonds parallel to the long axis of the fiber [52]. To date, a considerable 
number of PAs have been reported in the literature [70], including molecules with different hydrophobic 
tails [71–73]. For example, PAs comprised of a similar peptide sequence but with either saturated or 
diene-containing hexadecyl lipid chains self-assemble into polydisperse nanotapes or spherical micelles, 
respectively [44,74]. These examples illustrate the versatility of PAs, where increasing unsaturation and 
length of the lipid chains, or changing from alkyl to aromatic tails dramatically alters the final 
architecture of the self-assembled nanostructures [75]. However, this feature might compromise  
the stability, physical properties, and function of the PA, namely when exposed to UV [76] and  
γ-irradiation [77], two common sterilization methods used in materials for biological applications. 
Moreover, the concentration in which these molecules are used may constitute an important factor 
defining their self-assembled architecture [78] and bio-compatibility [42].  
 
Figure 2. Examples of supramolecular PA nanostructures. Graphical representation of some 
representative structures obtained by PAs self-assembly: (A) nanofibers; (B) micelles;  
and (C) multi-layered nanotapes. All three structures have a hydrophilic outer corona 
comprised of bioactive peptide (blue) and self-assembly-inducing/spacer sequence (white), 
and a hydrophobic inner core with organized and/or non-organized PA tails (red and green, 
respectively) (adapted from [63,79]). 
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Some of the main applications of PAs in regenerative medicine are summarized in Table 1. As 
reported in Table 1, PAs can be used in different forms, such as in coatings, in solution, or as hydrogels. 
All of these forms have been quite extensively tested, however, in spite of the advantages of using PAs 
in hydrogel form, it has to be considered that they exhibit poor mechanical characteristics [80]. In this 
context, the use of PAs as hydrogels is less suited to the production of scaffolds for engineering tissues 
requiring high mechanical strength and integrity. Considering the application of PAs in the field of tissue 
engineering, these molecules have been used by several groups towards the development of engineered 
constructs, particularly for the regeneration of connective tissues with a collagen-rich extracellular 
matrix. In order to achieve this objective using scaffold-based approaches, an artificial PA scaffold 
should mimic the structure and biological function of the native extracellular matrix as much as possible, 
both in terms of chemical cues and physical and mechanical properties. The native extracellular matrix 
provides structural support to body tissues, acting not only as a physical framework for arranging cells 
within the connective tissues, but also as a dynamic and flexible substance defining cellular behaviour 
and tissue function [81]. Indeed, it has been shown that the supramolecular network formed by  
self-assembled PA mimics, from a structural point of view, the natural extracellular matrix, albeit in a 
simplified way. In this context, the main applications of PAs molecules, so far, have been in the repair 
of bone [82,83], cartilage and tendon [84], blood vessels [85,86], cavernous nerves [87], skin [88,89], 
and importantly for this review, the cornea [44,74]. 
5. Peptide Amphiphiles as Versatile Templates to Recreate Human Corneas in vitro 
Various biomaterials have been explored for use in tissue engineered corneal substitutes, including, 
but by no means limited to, collagen [23,90,91], fibrin-agarose [8], decellularised cornea [92], and 
amniotic membrane [93,94]. Considering the high transparency of the corneal tissue, it is fundamental 
to design a scaffold preserving this characteristic whilst maintaining a high biocompatibility and a low 
immunogenicity [95]. In addition, there is a strong need to develop novel bioactive materials able to 
support cell adhesion and proliferation. In this context, PAs are well placed in that they can be designed 
to support a range of cell types important to corneal function, i.e. keratocytes, epithelial and endothelial 
cells. In this case the use of PAs would not only support the formation of extracellular matrix-inspired 
nanofibers following the self-assembly, but also enhance adhesion, proliferation, and alignment of 
human corneal stromal fibroblasts due to the insertion of specific bioactive motives. Notable research 
involving PAs in cornea tissue engineering are reported in Table 2. 
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Table 1. Main works involving the use of peptide amphiphiles in regenerative medicine. The table reports the PA used, its chemical structure, 
the aim of the studies, the source of the bioactive sequence, the concentration of PA used, and its form. 
PA Chemical Structure Aim Source [PA] wt % PA Form Reference 
C16-C4-G3-S-RGD 
Bone  
regeneration 
Fibronectin 0.1 coating [83] 
C12-HSNGLPLGGGS 
EEEAAAVVV(K) 
 
Cartilage  
regeneration 
De novo  
synthetized 
1 hydrogel [84] 
C16-V2A2E2-NH2 
Cavernous nerve 
regeneration 
De novo  
synthetized 
0.85 hydrogel [87] 
C16-C4-G3-  
LRKKLGKA 
Blood vessels  
regeneration 
Heparin binding  
consensus sequence 
3 hydrogel [85] 
C16-KTTKS 
Skin  
regeneration 
Procollagen I 0.0003 solution [88] 
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Table 2. Main works involving the use of peptide amphiphiles in corneal tissue engineering. The table reports the PA used, the source of the 
bioactive sequence, the PA biological effect, the concentration of PA used, and its form. 
PA Source Biological Effect [PA] wt % PA Form Reference 
C16-G3-RGD/RGDS  
+ C16-ETTES 
Fibronectin Enhanced adhesion and proliferation of hCSFs 1 to 0.005 coating [42,96] 
A6-RGDS  Fibronectin Enhanced adhesion and proliferation of hCSFs 1 to 0.1 coating [97] 
C16-TPGPQGIAGQ-RGDS 
MMP cleavage 
sequence + Fibronectin 
Promoted adhesion andgrowth of hCSFs. Stimulated 
collagen production. Governed tissues lift-up 
2 coating [44,74] 
Fmoc-RGDS Fibronectin Enhanced cell attachment, proliferation and viability 1 solution [43] 
C16-KTTKS Procollagen I Stimulated collagen production from hCSFs 0.002, 0.004, 0.008 solution [98,99] 
C12-VVAGKYIGSR Laminin 
Enhanced keratocyte proliferation and migration, 
and stimulated collagen I synthesis 
0.2 coating [100] 
C16-YEALRVANEVTLN Lumican Stimulated collagen I production 
0.01, 0.005, 0.0025 
0.00125, 0.000625 
solution [101] 
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For corneal tissue engineering one of the most used bioactive sequences is represented by the 
fibronectin derived RGD motive. As extensively reported, this sequence is frequently used for creating 
adhesive biomaterials able to promote cell interaction and adhesion through binding to integrin 
subgroups like those composed of subunits αV, α3β1, and α5β1 [102,103]. However, even if the 
tripeptide motif RGD has been identified as a minimal essential cell adhesion sequence [104], the 
definition of the minimo optimo bioactive epitope required in order to have the same function as the 
whole protein, is still not known. In this respect, Castelletto et al. [96] studied the self-assembly of two 
PAs designed ad hoc to enhance the potential for cell attachment. These peptides contained RGD or 
RGDS bioactive motives as well as a functional spacer in the β-sheet domain, consisting of a sequence 
of three consecutive glycine (G) residues. In addition, they optimized the potential for cell attachment 
by co-assembling the bioactive PA (RGD or RGDS) with a non-bioactive PA acting as a diluent 
molecule able to vary the RGD density within its supramolecular form following self-assembly above 
critical aggregation concentration. In particular, they used a negatively charged PA composed of  
C16-Glu-Thr-Thr-Glu-Ser (C16-ETTES) as this diluent. Castelletto et al. posited that by tuning the diluent 
concentration, so the distance between neighbouring RGD groups would be greater than that in the 
undiluted RGD(S)-PA following self-assembly, they could optimize the PA for maximal cell attachment. 
When such a PA mixture was subsequently used as a coating for 2D human keratocyte attachment and 
growth, the optimal molar ratio of C16-RGD(S):C16-ETTES was found to be 15:85. Subsequently, this 
approach was employed by Gouveia et al. [42] to produce stable biocompatible film coatings which 
enhanced adhesion, proliferation and alignment of human corneal stromal fibroblasts whilst inducing 
the formation of 3D lamellar-like stromal tissue. These early results suggested that such mixtures of PAs 
constitute a promising new material capable of directing corneal stromal cells to produce appropriate 
amounts and type of extracellular matrix that are likely to be important to both corneal wound healing 
and tissue engineering. However, the biophysical, mechanical, and biological properties of these 
functional coatings require further extensive research. Castelletto et al. [97] also demonstrated the ability 
to produce bioactive film coatings for corneal stromal cell growth using an alanine-rich amphiphilic 
peptide containing the RGD motive (A6-RGD). This PA was designed to simultaneously ensure 
solubility in water and specific binding to cells. They found that the self-assembly motive depended on the 
concentration of surfactant-like peptide (SLP) and demonstrated the co-existence of vesicles and fibres 
with an increase in vesicle population relative to fibres when the SLP concentration increases. Moreover, 
at low concentrations (0.1 wt % –1.0 wt %), this SLP promoted adhesion and enhanced proliferation of 
human corneal stromal cells. Thus, A6-RGD PA represents another promising bioactive peptide for the 
manufacture of dry coatings for cornea tissue engineering. 
More recently, a study by Gouveia et al. [74] described an inventive way to take advantage of PA 
film coatings for corneal tissue engineering. In this work, they described a biologically interactive PA 
coating that integrated both the abilities to induce tissue bio-fabrication and the subsequent tissue  
self-release in vitro. This was made achievable by employing a custom designed PA comprised a matrix 
metalloprotease (MMP)-cleavable sequence (Thr-Pro-Gly-Pro-Gln-Gly-Ile-Ala-Gly-Gln) followed by 
the RGDS bioactive motive which, as before, was mixed with C16-ETTES at a molar ratio of 15:85. The 
subsequent self-assembly studies revealed that the PA self-assembled into nanotapes that were also 
capable of forming film coatings providing a stable surface for the attachment and growth of human 
corneal stromal cells in a quiescent phenotype. Furthermore the supplementation of all-trans retinoic 
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acid (RA) to the culture media facilitated both retained cellular attachment and ultimately tissue 
formation via cell stratification. Previously Gouveia and Connon [105] had shown that the addition of 
RA inhibits the expression of several MMPs from the cells while enhancing their native extracellular 
matrix production. Thus, in the presence of the MMP-sensitive PA coating, the cells increased MMP 
expression and endogenous proteolytic activity following RA removal. The resulting increase in 
proteolytic activity in the culture supernatant cleaved the RGD peptide from the self-assembled PA (i.e., 
the nanotape structures underpinning the tissue growth) facilitating the complete detachment of the tissue 
from the bioactive surface, and creating a free-floating construct (Figure 3). As such, this smart PA 
material represents a new and fascinating method for the bio-fabrication of certain structural tissues 
including corneal stromal equivalents. 
 
Figure 3. Bio-fabrication and controlled self-release of live tissues using PA coating 
templates. Schematic representation of the method used for the in vitro bio-fabrication and 
lift-off of human corneal stromal tissues, previously reported in [74]. Cells isolated from 
human donors were seeded and grown on low-attachment plates previously coated with a 
PA carrying both the MMP1-sensitive sequence and the RGDS cell adhesion motive. Cells 
were cultured in serum-free medium containing retinoic acid (RA) for 90 days and 
accumulated large quantities of corneal-specific stromal extracellular matrix. Subsequently, 
the bio-fabricated tissues were induced to express MMPs due to RA removal from the 
medium. In three days, the tissues expressed enough endogenous MMPs into the culture 
supernatant to provide the cue to degrade the adhesive PA coating, and induce their own 
release. The resulting free-floating corneal stromal equivalents were scaffold-free, easy to 
handle, and retained their shape and structural integrity for more than 18 months  
in storage.  
PAs have not only been shown to augment the amounts of extracellular matrix produced by corneal 
stromal cells. For instance, PAs were also used to successfully control the form and shape of corneal 
tissue-engineered constructs. It is known that during embryonic development, corneal fibroblasts play a 
central role in exerting physical forces that organize the extracellular matrix into a unique pattern 
providing structural support whilst maintaining tissue transparency [106–110]. Furthermore, corneal 
fibroblasts guide wound contraction and matrix remodeling after injury or refractive surgery [14,111,112]. 
In the physiological process of corneal wound healing, quiescent corneal keratocytes switch to the 
fibroblast phenotype and migrate through the tridimensional matrix to restore it. In order to investigate 
cell-matrix mechanical interactions during fibroblast migration, Petroll et al. [113,114] developed a 
model in which cell-seeded compressed collagen matrices are nested within acellular uncompressed 
matrices. They found that matrices cultured in medium containing exogenous serum become 
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significantly deformed due to keratocytes’ activation and migration into the outer matrix [115]. Similar 
levels of matrix contraction can disrupt or damage the unique and functional architecture of the corneal 
stroma leading to the formation of scars or fibrosis. Therefore, a method able to limit it or to stimulate a 
low contractility migration is highly required. In this respect, a new approach for the containment of the 
collagen contraction by corneal fibroblasts has been developed through the novel use of PAs. In this 
example, again by Gouveia et al. [43], hybrid materials were constructed comprising fibrillar collagen 
type I and a PA formed from Fmoc-RGDS. Once encapsulated within this mixture, and exposed to 
serum, human keratocytes were unable to contract the collagen gel as they would normally (Figure 4). 
It is believed that this hybrid collagen PA system forms an interpenetrating “gel within a gel” and that 
the cells preferential bind to the Fmoc-RGDS motif inhibiting the cells from binding to and contracting 
the collagen gel in the presence of serum. Thus the degree of tissue contraction and shape was controlled 
by the concentration of the Fmoc-RGDS PA within the system. This interesting study opens up the 
possibility of using PAs to control localized effects on cells in a three-dimensional environment, thereby 
lifting the veil on much more complicated tissue-engineered constructs rather than the homogenous 
forms that are prevalent today. 
 
Figure 4. Schematic representation of the effect of Fmoc-RGDS PA on collagen gel 
contraction under different culture conditions. Human corneal stromal fibroblasts were 
encapsulated within uncompressed collagen gels that have been functionalized with the 
fibril-forming Fmoc-RGDS PA (+fPA), or produced without it (CTR). The relative 
contraction of collagen gels after seven days in serum-free medium (SFM) was negligible, 
but significantly minimized by the presence of the structural PA in serum-containing media 
alone (+FBS) or supplemented with 50 µM of soluble PA (+sPA) or cyclic RGD peptide 
(+cRGD) (adapted from [43]). 
Another PA showing promising application in corneal wound repair is represented by C16-KTTKS. 
This particular peptide is used in anti-wrinkle cosmeceutical applications under the trade name of 
Matrixyl. In the first published study on the effects of this commercially available PA, Castelletto et al. [98] 
investigated the self-assembly of this PA in aqueous solution, observing tape-like nanostructures with a 
broad distribution of widths and reporting that the internal structure of these nanotapes comprised PA 
bilayers. Subsequently, the work of Jones et al. [99] showed that this peptide was able to stimulate 
collagen production from human corneal stromal cells (as well as dermal fibroblasts) in a  
concentration-dependent manner. This finding paved the way for a more recent investigation using 
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another potent extracellular matrix stimulatory peptide sequence in the form of a PA. In this case the 
bioactivity of a PA presenting a lumican-derived bioactive sequence (C16-YEALRVANEVTLN) was 
studied [101]. Lumican is a proteoglycan playing a structural role through binding to fibrillar collagens 
and modulating fibril formation whilst regulating interfibrillar spacing. The choice of this specific 
sequence is due to the fact that previous studies have shown it to have matrikine properties [116] such 
as creating chemokine gradients [117] and promoting the healing of corneal epithelial wounds [118]. 
Interestingly, this PA self-assembled in twisting and curving tape-like structures, on the borderline 
between nanotape and fibril structures. Regarding its functionality, this PA has been shown to stimulate 
collagen production in a concentration-dependent manner, indicating its potential use in tissue 
engineering and bio-fabrication. A further highly-represented protein family in the extracellular matrix 
is that of laminins. It is well known that laminins trigger and control many cellular functions [119], 
rendering them suitable candidates for the design of new bioactive PAs. In this respect, Uzunalli et al. [100] 
reported an interesting study regarding the application of a PA carrying a laminin-derived sequence for 
corneal stroma regeneration. In particular, this peptide contained the sequence YIGSR derived from 
laminin β-chain, which regulates cell adhesion through binding to the laminin binding protein (LBP). 
Their results demonstrated that the PA containing the laminin-derived sequence enhanced cell 
proliferation, keratocyte migration, and collagen I synthesis, both from in vitro and in vivo, and to a 
greater extent compared to the more commonly used RGD-PA. For this reason, this specific bioactive 
sequence should be considered (alongside the others previously mentioned) in future studies involving 
corneal stroma bio-fabrication and regeneration.  
6. Future Perspectives 
It can be argued that PAs are “eclectic” molecules, a notion related to the fact that: (1) these molecules 
can be used in different forms (e.g., as colloidal solutions or hydrogels, as well as thin coating films); 
(2) PAs can self-assemble in distinct supramolecular structures depending on the molecule’s chemical 
structure; (3) PAs can have a wide range of biological activities depending on the type and number of 
bio-functional motives incorporated; (4) PAs can be easily designed and used by researchers with limited 
expertise in synthetic and organic chemistry; and (5) PAs can be used for various and specific 
applications in multiple fields, including biochemistry, stem cell biology, biotechnology, and 
regenerative medicine. Upon evaluating the state-of-the-art on the application of PAs in corneal tissue 
engineering, it is evident that intriguing and promising results have  been achieved recently. In this 
regard, the potential next step would involve studies concerning the response and the mechanism of 
integration of these constructs in animal models, eventually followed by clinical trials. From this review, 
the possibility of abandoning scaffolds (i.e., the top-down approach) also emerges . Indeed, it has been 
shown that the bio-fabrication of corneal stromal tissue can be achieved entirely by human keratocytes 
instructed by a smart, multi-functional PA coating template. Despite the challenges involved in this 
work, current research constitutes the foundation and inspiration for the bio-fabrication of other corneal 
tissues. With such a premise, it is reasonable to conduct further studies in order to further produce  
multi-cellular, multi-layered, whole-thickness corneas in vitro. Moreover, the production of such 
artificial constructs paves the way for a wider range of applications. For instance, bio-fabricated corneal 
constructs could be used in pharmacological studies as models to test the effect of new drugs rather than 
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using animals. Indeed, the development of alternative methods that avoid or significantly reduce the use 
of animals for scientific purposes is still an important issue. In addition, PA templates could be designed 
to bio-fabricate both corneal and other connective tissues using other cell sources, such as mesenchymal 
or induced pluripotent stem cells, instead of adult cells. This strategy would be useful for creating  
multi-cellular constructs in one step, possibly through the use of patterned, multi-component PA systems 
with numerous specific bioactive peptide motives designed to affect individual cell types. Moreover, 
since the native ECM proteins are exceptionally multifunctional while PAs typically only possess one 
bioactive sequence, it would be extremely interesting to design and extensively test the self-assembling 
and function of PAs carrying more than one epitope, or combine different bioactive PAs molecules in 
the same system. 
7. Conclusions 
The range of applications for PA-based nanomaterials is steadily expanding, with emerging uses as 
modulators of extracellular matrix production, and as templates of increasingly complex structure and 
composition. This wide range of purposes is rooted in the fact that PAs can be rationally designed, and 
where the primary, secondary, and tertiary structures of PAs depend on the a priori aim of the study. 
Moreover, the use of PAs is continuously evolving, with new discoveries on the function of specific 
peptide motives and advances in understanding supramolecular chemistry facilitating the development 
of novel molecules. Although there are several studies involving the use of PAs in biological systems, 
few are focusing on their application in corneal tissue engineering and repair. This review has 
highlighted this nascent but potentially useful specialized field, and demonstrates what can be achieved 
from interdisciplinary collaboration among researchers from the physical, chemical, biological, and 
clinical sciences. In this context, the current PA studies represent an important step in the change of 
paradigm for tissue engineering and regenerative medicine.  
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